Abstract
Serum 5′-Nucleotidase as a Novel Predictor of Adverse Clinical Outcomes after Percutaneous Coronary Intervention in Patients with Coronary Artery Disease
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have